We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
Cap. Flow
+$281M
Cap. Flow %
7.02%
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$104M
2
AAPL icon
Apple
AAPL
+$60.7M
3
AMZN icon
Amazon
AMZN
+$47.5M
4
AXP icon
American Express
AXP
+$28.7M
5
TRV icon
Travelers Companies
TRV
+$27.2M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$28.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.1M
3
CLX icon
Clorox
CLX
+$26.2M
4
TJX icon
TJX Companies
TJX
+$24.8M
5
MCK icon
McKesson
MCK
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.39%
2 Financials 11.87%
3 Technology 10.68%
4 Communication Services 10.67%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEP icon
351
American Electric Power
AEP
$73.7B
$1.55M 0.04%
+23,432
New +$1.45M
CHRW icon
352
C.H. Robinson
CHRW
$22B
$1.54M 0.04%
20,856
+1,494
+8% +$103K
EQR icon
353
Equity Residential
EQR
$25.4B
$1.54M 0.04%
20,625
-3,929
-16% -$294K
GMED icon
354
Globus Medical
GMED
$10.4B
$1.51M 0.04%
64,000
+28,000
+78% +$684K
TROW icon
355
T. Rowe Price
TROW
$25B
$1.49M 0.04%
20,371
-8,078
-28% -$561K
DE icon
356
Deere & Co
DE
$170B
$1.49M 0.04%
19,389
-1,385
-7% -$108K
NOV icon
357
NOV
NOV
$7.45B
$1.48M 0.04%
47,799
+385
+0.8% +$11.8K
FPRX
358
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.46M 0.04%
36,000
-75,300
-68% -$2.59M
ALGN icon
359
Align Technology
ALGN
$12B
$1.45M 0.04%
+20,000
New +$1.31M
BLK icon
360
Blackrock
BLK
$164B
$1.44M 0.04%
4,237
+795
+23% +$252K
PNC icon
361
PNC Financial Services
PNC
$100B
$1.43M 0.04%
16,948
-4,870
-22% -$415K
EEM icon
362
iShares MSCI Emerging Markets ETF
EEM
$28B
$1.41M 0.04%
41,501
-375
-0.9% -$11.6K
APA icon
363
APA Corp
APA
$12.8B
$1.41M 0.04%
+29,074
New +$1.21M
AKRX
364
DELISTED
Akorn Inc
AKRX
$1.4M 0.04%
+60,000
New +$1.58M
NUVA
365
DELISTED
NuVasive, Inc.
NUVA
$1.4M 0.04%
29,000
+6,000
+26% +$272K
EFX icon
366
Equifax
EFX
$20.3B
$1.4M 0.04%
12,337
-1,683
-12% -$177K
DUK icon
367
Duke Energy
DUK
$102B
$1.38M 0.03%
17,173
-5,016
-23% -$380K
MHFI
368
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$1.38M 0.03%
13,967
+1,156
+9% +$104K
DVAX
369
DELISTED
Dynavax Technologies
DVAX
$1.37M 0.03%
+71,500
New +$1.44M
CKEC
370
DELISTED
Carmike Cinemas Inc
CKEC
$1.34M 0.03%
+45,000
New +$1.09M
GPC icon
371
Genuine Parts
GPC
$17.1B
$1.33M 0.03%
13,446
+1,069
+9% +$94.8K
MS icon
372
Morgan Stanley
MS
$337B
$1.33M 0.03%
53,404
+5,994
+13% +$153K
K
373
DELISTED
Kellanova
K
$1.32M 0.03%
18,449
+9,636
+109% +$665K
EXC icon
374
Exelon
EXC
$48.6B
$1.32M 0.03%
51,812
-11,600
-18% -$260K
TRVN
375
DELISTED
Trevena, Inc.
TRVN
$1.32M 0.03%
+256
New +$1.29M

Similar funds

Candriam SCA's Q1 2016 Portfolio in Review

As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.

  • Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
  • Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
  • Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
  • Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
  • Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
  • Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
  • Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.

Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.